Overview

Blood Pressure Outcomes With Liraglutide Therapy

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

Purpose: The purpose of this study is to further study the mechanism by which liraglutide, a relatively new anti-hyperglycemic medication, might lower blood pressure in patients with Type 2 diabetes and high blood pressure.

Phase:

Phase 4

Details

Lead Sponsor:

Mount Sinai Hospital, Canada

Collaborator:

Novo Nordisk A/S

Treatments:

Glucagon-Like Peptide 1
Liraglutide